Study design: Real-world data, real impact Using a target trial emulation framework, researchers analyzed Truveta Data and compared adults with AUD and either type 2 diabetes or obesity who started a GLP-1 RA to similar individuals starting alternative medications
PMID: 10827002
In foundational research, GLP-1 secretion was significantly blunted in animals lacking the FFAR2 receptor, pinning down the mechanism directly
Gallbladder disease (including gallstones and cholecystitis) has been reported with GLP-1 receptor agonists, particularly with substantial weight loss
How to File a Zepbound Lawsuit To file a Zepbound lawsuit: Set up an initial consultation with an experienced attorney
Taking a dose too early may slightly increase the risk of side effects such as nausea, vomiting, or abdominal discomfort, but is unlikely to affect the overall effectiveness of treatment